Peer-reviewed veterinary case report
Chemotherapy outcomes for cats with high-grade intestinal lymphoma
By Bernardo Marques, Grégoire et al.·Published in Veterinary and comparative oncology·2024·Université, France·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Feline high-grade and large granular lymphocyte alimentary lymphomas treated with COP- or CHOP-based chemotherapy: A multi-centric retrospective study of 57 cases.
- Species:
- cat
Plain-English summary
A group of 57 cats diagnosed with high-grade or large granular lymphocyte lymphoma (a type of cancer affecting the intestines) were treated with chemotherapy protocols called COP or CHOP. About 42% of the cats responded to treatment, with some showing complete or partial improvement. On average, cats that responded to treatment lived longer, with a median survival time of about 131 days. Factors that helped improve survival included receiving additional rescue treatments and not having lymph node involvement, while more severe cases with widespread gastrointestinal issues had poorer outcomes.
People also search for: cat lymphoma treatment · feline chemotherapy success rates · cat cancer survival time
Abstract
Specific data regarding outcome of cats with high-grade and large granular lymphocyte alimentary lymphoma (HGAL and LGL, respectively) treated with multi-agent chemotherapy are scarce. The aims of this multi-centric, retrospective study were to describe the outcome of cats with HGAL and LGL treated with COP- or CHOP-based chemotherapy and to identify potential prognostic factors. Cats with a cytological or histological diagnosis of HGAL or LGL lymphoma treated with COP- or CHOP-based protocol as first-line chemotherapy were included. Data regarding diagnosis, staging, treatment and follow-up were collected. Fifty-seven cats treated with CHOP (n = 37) or COP (n = 20) protocols were included. Complete response (CR), partial response (PR), stable disease (SD) and progressive disease (PD) were observed in 20%, 22%, 36% and 22% of cats, respectively, for an overall response rate of 42%. Median progression-free interval (PFI) was 148 days and overall median survival time (OST) was 131 days. Cats achieving CR, PR or SD showed significantly longer PFI (p < .01) and OST (p < .015) compared with cats with PD. Other positive prognostic factors in multi-variate analysis were rescue treatment (p < .001) and absence of lymph node involvement (p < .03). Negative prognostic factors were diffuse infiltration of the gastrointestinal tract (p = .035) and infiltration of a non-haematopoietic organ (p < .01).
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/38356238/